PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CME vs. NDAQ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


CMENDAQ
YTD Return0.69%3.79%
1Y Return19.84%11.47%
3Y Return (Ann)5.34%5.37%
5Y Return (Ann)7.25%16.73%
10Y Return (Ann)16.14%19.32%
Sharpe Ratio1.130.56
Daily Std Dev17.20%22.91%
Max Drawdown-77.50%-68.48%
Current Drawdown-7.52%-12.14%

Fundamentals


CMENDAQ
Market Cap$75.94B$34.61B
EPS$8.78$1.87
PE Ratio24.0332.15
PEG Ratio8.461.98
Revenue (TTM)$5.62B$6.21B
Gross Profit (TTM)$5.01B$3.58B
EBITDA (TTM)$3.86B$2.19B

Correlation

-0.50.00.51.00.5

The correlation between CME and NDAQ is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

CME vs. NDAQ - Performance Comparison

In the year-to-date period, CME achieves a 0.69% return, which is significantly lower than NDAQ's 3.79% return. Over the past 10 years, CME has underperformed NDAQ with an annualized return of 16.14%, while NDAQ has yielded a comparatively higher 19.32% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


1,500.00%2,000.00%2,500.00%3,000.00%3,500.00%4,000.00%4,500.00%5,000.00%NovemberDecember2024FebruaryMarchApril
4,624.83%
1,963.43%
CME
NDAQ

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


CME Group Inc.

Nasdaq, Inc.

Risk-Adjusted Performance

CME vs. NDAQ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for CME Group Inc. (CME) and Nasdaq, Inc. (NDAQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CME
Sharpe ratio
The chart of Sharpe ratio for CME, currently valued at 1.13, compared to the broader market-2.00-1.000.001.002.003.004.001.13
Sortino ratio
The chart of Sortino ratio for CME, currently valued at 1.67, compared to the broader market-4.00-2.000.002.004.006.001.67
Omega ratio
The chart of Omega ratio for CME, currently valued at 1.21, compared to the broader market0.501.001.501.21
Calmar ratio
The chart of Calmar ratio for CME, currently valued at 0.75, compared to the broader market0.002.004.006.000.75
Martin ratio
The chart of Martin ratio for CME, currently valued at 6.65, compared to the broader market0.0010.0020.0030.006.65
NDAQ
Sharpe ratio
The chart of Sharpe ratio for NDAQ, currently valued at 0.56, compared to the broader market-2.00-1.000.001.002.003.004.000.56
Sortino ratio
The chart of Sortino ratio for NDAQ, currently valued at 0.84, compared to the broader market-4.00-2.000.002.004.006.000.84
Omega ratio
The chart of Omega ratio for NDAQ, currently valued at 1.13, compared to the broader market0.501.001.501.13
Calmar ratio
The chart of Calmar ratio for NDAQ, currently valued at 0.41, compared to the broader market0.002.004.006.000.41
Martin ratio
The chart of Martin ratio for NDAQ, currently valued at 1.52, compared to the broader market0.0010.0020.0030.001.52

CME vs. NDAQ - Sharpe Ratio Comparison

The current CME Sharpe Ratio is 1.13, which is higher than the NDAQ Sharpe Ratio of 0.56. The chart below compares the 12-month rolling Sharpe Ratio of CME and NDAQ.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.00NovemberDecember2024FebruaryMarchApril
1.13
0.56
CME
NDAQ

Dividends

CME vs. NDAQ - Dividend Comparison

CME's dividend yield for the trailing twelve months is around 4.60%, more than NDAQ's 1.46% yield.


TTM20232022202120202019201820172016201520142013
CME
CME Group Inc.
4.60%4.58%5.05%3.00%3.24%2.74%2.42%4.20%4.90%5.41%4.38%5.61%
NDAQ
Nasdaq, Inc.
1.46%1.48%1.27%1.00%1.46%1.73%2.08%1.90%1.80%1.55%1.21%1.31%

Drawdowns

CME vs. NDAQ - Drawdown Comparison

The maximum CME drawdown since its inception was -77.50%, which is greater than NDAQ's maximum drawdown of -68.48%. Use the drawdown chart below to compare losses from any high point for CME and NDAQ. For additional features, visit the drawdowns tool.


-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%NovemberDecember2024FebruaryMarchApril
-7.52%
-12.14%
CME
NDAQ

Volatility

CME vs. NDAQ - Volatility Comparison

The current volatility for CME Group Inc. (CME) is 5.06%, while Nasdaq, Inc. (NDAQ) has a volatility of 5.62%. This indicates that CME experiences smaller price fluctuations and is considered to be less risky than NDAQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%8.00%9.00%NovemberDecember2024FebruaryMarchApril
5.06%
5.62%
CME
NDAQ

Financials

CME vs. NDAQ - Financials Comparison

This section allows you to compare key financial metrics between CME Group Inc. and Nasdaq, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items